Virtual Medicinal Product (VMP) - Co-amoxiclav 250mg/125mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amoxiclav 250mg/125mg tablets | Start Date 04-05-2004 | End Date |
| Previous Name | Previous Name Co-amoxiclav 250/125 tablets | Start Date SOT |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- J01CR02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05010103 | Start Date 04-04-2022 | End Date |
| Previous BNF 05010103 | Start Date 01-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 39732111000001101 | 27-05-2021 | |
| 323563001 | SOT | 26-05-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amoxicillin trihydrate | Based on Base Substance | Amoxicillin | 250 mg | |
| Potassium clavulanate | Based on Base Substance | Clavulanic acid | 125 mg |
Name
Amoxicillin trihydrate
Basis of strength description
Based on Base Substance
BOSS
Amoxicillin
Strength and UOM (Nmr)
250
Strength and UOM (Dmr)
Name
Potassium clavulanate
Basis of strength description
Based on Base Substance
BOSS
Clavulanic acid
Strength and UOM (Nmr)
125
Strength and UOM (Dmr)
Parent Products
-
VTMCo-amoxiclav
-
VMP(Current) Co-amoxiclav 250mg/125mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 21 tablet | 335 | Part VIIIA Category M |
| 100 tablet |